Wullich B, Taubert H, Goebell P, Kuwert T, Beck M, Schott C, Baur A, Eckstein M, Wach S (2023)
Publication Type: Journal article, Review article
Publication year: 2023
DOI: 10.1007/s00120-023-02151-z
Spectacular advances have been made in personalized medicine , which has rapidly revolutionized our traditional understanding of disease diagnosis and treatment. Molecular testing of tissue and liquid samples using next generation sequencing has developed into a key technology in this scenario. It can be used for both the determination of biomarkers for diagnostic, prognostic and predictive purposes, as well as the possible improvement of treatment outcome through the use of targeted therapies and the avoidance of therapies in the event of special resistance situations. In addition to drugs that have already been approved, which among other things intervene in cellular DNA repair, many new drugs have been developed and are in clinical testing. Furthermore, new possibilities in molecular imaging have dramatically expanded our understanding of tumor spread and created new approaches for targeted therapies.
APA:
Wullich, B., Taubert, H., Goebell, P., Kuwert, T., Beck, M., Schott, C.,... Wach, S. (2023). Individualisierte Präzisionsmedizin. Die Urologie. https://doi.org/10.1007/s00120-023-02151-z
MLA:
Wullich, Bernd, et al. "Individualisierte Präzisionsmedizin." Die Urologie (2023).
BibTeX: Download